Literature DB >> 401485

Effects of estrogen on thyroxine-binding globulin metabolism in rhesus monkeys.

D Glinoer, R A McGuire, M C Gershengorn, J Robbins, M Berman.   

Abstract

To investigate the effects of estrogen on thyroxine-binding globulin (TBG) metabolism, 4 female Rhesus monkeys were studied before and 3-4 weeks after implantation of beta-estradiol (E2)-containing capsules. In addition, 2 of the animals were also studied for the first 7 days after the start of E2. Serum E2 increased 10-fold from 20 +/- 7 to 212 +/- 41 pg/ml. Serum TBG, initially 20.2 +/- 6 mug/ml, was elevated by 24 h after E2 implantation, and reached a steady level of 46.8 +/- 5.0 mug/ml by 7-10 days. For the turnover studies, highly purified [125I]iodo-TBG was injected iv and serum [125I]PBI and urinary 125I excretion were measured daily. TBG kinetics were evaluated by use of a compartmental model. Although a 2-compartment model was sufficient to fit the control and late E2 data, a 3-compartment model was developed in order to account for the modifications observed during the early E2 period. The final decay rate (k) of TBG was 0.26 +/- 0.01/day during the control period and was slightly lower after E2 (0.23 +/- 0.01/day). In the 2 monkeys studied during the early E2 period, the major effect of E2 was a stimulation of the TBG production rate. This was simulated in the model by a stepwise increase occurring in the last quarter of the first day after E2. There was also an abrupt redistribution of TBG in the compartments defined by the model. The total distribution or serum equivalent volume of TBG after 3-4 weeks of E2 increased 1.4-fold, from 338 +/- 37 ml to 458 +/- 22 ml, and the metabolic clearance rate increased 1.3-fold, from 90 +/- 10 ml/d to 113 +/- 12 ml/d. The increase in the final TBG production rate (2.9-fold) was only slightly greater than the rate calculated for the early E2 period, and was similar to the increase we have recently found in monkey hepatocytes studied in vitro after isolation from E2-treated animals. It appears that stimulation of hepatic synthesis of TBG accounts for the elevated serum levels of TBG observed after estrogen.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 401485     DOI: 10.1210/endo-100-1-9

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Use of direct thyroxine-binding globulin measurement in the evaluation of thyroid function.

Authors:  D Glinoer; M Fernandez-Deville; A M Ermans
Journal:  J Endocrinol Invest       Date:  1978-10       Impact factor: 4.256

Review 2.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

3.  Oxidative stress elevated DNA damage and homocysteine level in normal pregnant women in a segment of Pakistani population.

Authors:  Shazia A Bukhari; Muhammad Ibrahim Rajoka; Z Ibrahim; Fatima Jalal; Shahid Mahboob Rana; Saeed A Nagra
Journal:  Mol Biol Rep       Date:  2010-11-24       Impact factor: 2.316

4.  Donor gender does not affect liver transplantation outcome in children.

Authors:  P Pillay; D H Van Thiel; J S Gavaler; T E Starzl
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

5.  Do elevated TSH levels predict early pregnancy loss in ART patients?

Authors:  Julian A Gingold; Kelly Zafman; Jorge Rodriguez-Purata; Michael C Whitehouse; Joseph A Lee; Benjamin Sandler; Alan B Copperman
Journal:  Gynecol Endocrinol       Date:  2016-07-16       Impact factor: 2.260

6.  Thyroxine replacement for subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism.

Authors:  M Ahsan Akhtar; Rina Agrawal; Julie Brown; Yasmin Sajjad; Laurentiu Craciunas
Journal:  Cochrane Database Syst Rev       Date:  2019-06-25

7.  Meta-analysis of ART outcomes in women with different preconception TSH levels.

Authors:  T Zhao; B M Chen; X M Zhao; Z Y Shan
Journal:  Reprod Biol Endocrinol       Date:  2018-11-05       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.